Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Denileukin diftitox

EU orphan designation number: EU/3/01/075   
Active ingredient: Denileukin diftitox
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Eisai Limited
European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/12/2001 Centralised Orphan - Designation EMEA/OD/038/01 (2001)4110 of 11/12/2001
13/02/2004 Other procedure
27/03/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/038/01/T/01 (2007)1449 of 23/03/2007
23/07/2009 Other procedure